PriceTargets.com logo

Hyperfine - HYPR Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $1.60
  • Forecasted Upside: 61.62%
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$0.99 As of 12/3/2024 12:53 PM ET
▼ -0.01 (-1.00%)

This chart shows the closing price for HYPR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Hyperfine Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HYPR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HYPR

Analyst Price Target is $1.60
▲ +61.62% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Hyperfine in the last 3 months. The average price target is $1.60, with a high forecast of $1.60 and a low forecast of $1.60. The average price target represents a 61.62% upside from the last price of $0.99.

This chart shows the closing price for HYPR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 2 polled investment analysts is to moderate buy stock in Hyperfine. This rating changed within the last month from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
6/12/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
3/8/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
6/6/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
9/4/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
11/3/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/3/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/22/2024Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$2.10 ➝ $1.60
12/12/2023B. RileyReiterated RatingBuy
11/30/2023Jefferies Financial GroupInitiated CoverageHold$1.25
8/15/2023B. RileyBoost TargetBuy ➝ Buy$2.50 ➝ $3.50
3/22/2023B. RileyLower TargetBuy$3.50 ➝ $2.50
10/4/2022B. RileyInitiated CoverageBuy$3.50
8/11/2022Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$8.00 ➝ $2.40
5/31/2022Evercore ISIInitiated CoverageOutperform$7.00
4/14/2022Wells Fargo & CompanyInitiated CoverageOverweight$8.00
(Data available from 12/3/2019 forward)

News Sentiment Rating

0.27 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/7/2024
  • 3 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/6/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/6/2024
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/5/2024
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/4/2024
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/4/2024
  • 2 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/3/2024
  • 0 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/3/2024

Current Sentiment

  • 0 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

  • No very positive mentions tracked during this time.
Hyperfine logo
Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.
Read More

Today's Range

Now: $0.99
Low: $0.98
High: $1.01

50 Day Range

MA: $0.98
Low: $0.85
High: $1.08

52 Week Range

Now: $0.99
Low: $0.76
High: $1.39

Volume

24,126 shs

Average Volume

101,021 shs

Market Capitalization

$72.22 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.86

Frequently Asked Questions

What sell-side analysts currently cover shares of Hyperfine?

The following Wall Street sell-side analysts have issued research reports on Hyperfine in the last twelve months: B. Riley, and Wells Fargo & Company.
View the latest analyst ratings for HYPR.

What is the current price target for Hyperfine?

0 Wall Street analysts have set twelve-month price targets for Hyperfine in the last year. Their average twelve-month price target is $1.60, suggesting a possible upside of 61.6%. Wells Fargo & Company has the highest price target set, predicting HYPR will reach $1.60 in the next twelve months. Wells Fargo & Company has the lowest price target set, forecasting a price of $1.60 for Hyperfine in the next year.
View the latest price targets for HYPR.

What is the current consensus analyst rating for Hyperfine?

Hyperfine currently has 1 hold rating and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for HYPR.

What other companies compete with Hyperfine?

Other companies that are similar to Hyperfine include Perspective Therapeutics, Zynex, Pulmonx, Electromed and Profound Medical. Learn More about companies similar to Hyperfine.

How do I contact Hyperfine's investor relations team?

Hyperfine's physical mailing address is 55 HUDSON YARDS 28TH FLOOR, NEW YORK NY, 10001. The company's listed phone number is 866-796-6767 and its investor relations email address is [email protected]. The official website for Hyperfine is hyperfine.io. Learn More about contacing Hyperfine investor relations.